RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 108 filers reported holding RUBIUS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $10,000 | -82.1% | 23,784 | -64.0% | 0.00% | – |
| Q2 2022 | $56,000 | -73.1% | 66,129 | +75.1% | 0.00% | – |
| Q1 2022 | $208,000 | -22.4% | 37,765 | +151.8% | 0.00% | – |
| Q3 2021 | $268,000 | -78.2% | 15,000 | -70.2% | 0.00% | – |
| Q2 2021 | $1,228,000 | -65.7% | 50,300 | -62.7% | 0.00% | -100.0% |
| Q1 2021 | $3,578,000 | +4210.8% | 135,028 | +1130.1% | 0.00% | – |
| Q4 2020 | $83,000 | -46.1% | 10,977 | -64.2% | 0.00% | – |
| Q3 2020 | $154,000 | – | 30,642 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |